Viracta Therapeutics Inc (VIRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,615 | -35,458 | -38,023 | -36,676 | -43,002 |
| Depreciation Amortization | 201 | 278 | 370 | 162 | 396 |
| Accounts payable and accrued liabilities | -304 | -174 | -582 | -724 | 2,224 |
| Other Working Capital | -627 | -3,995 | -4,127 | -5,019 | -2,902 |
| Other Operating Activity | 2,941 | 3,207 | 5,400 | 3,526 | 103 |
| Operating Cash Flow | $-24,404 | $-36,142 | $-36,962 | $-38,731 | $-43,181 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -26 | N/A | N/A | -48 |
| Purchase Of Investment | N/A | N/A | -35,530 | -35,683 | -42,463 |
| Sale Of Investment | 4,780 | 29,774 | 20,531 | 36,930 | 45,836 |
| Investing Cash Flow | $4,780 | $29,748 | $-14,999 | $1,247 | $3,325 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 15,000 | N/A | N/A |
| Common Stock Issued | 6,343 | 28,297 | 20,788 | 27,367 | 56,277 |
| Other Financing Activity | 0 | -2,982 | -2,657 | 14,817 | -9,356 |
| Financing Cash Flow | $6,343 | $25,315 | $33,131 | $42,184 | $46,921 |
| Beginning Cash Position | 26,977 | 8,056 | 26,886 | 22,186 | 15,121 |
| End Cash Position | 13,696 | 26,977 | 8,056 | 26,886 | 22,186 |
| Net Cash Flow | $-13,281 | $18,921 | $-18,830 | $4,700 | $7,065 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,404 | -36,142 | -36,962 | -38,731 | -43,181 |
| Capital Expenditure | N/A | -26 | N/A | N/A | -48 |
| Free Cash Flow | -24,404 | -36,168 | -36,962 | -38,731 | -43,229 |